Motus Gi Holdings Inc 's ability to collect accounts receivable sequentially worsen to 3.58, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Motus Gi Holdings Inc 's Accounts Receivable average collection period in the Mar 31 2024 quarter, has increased to 102 days, from 96 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 506 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 0 to 3369.

What is Receivable Turnover Ratio?
What is Motus Gi Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MOTS Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	55.77 %	28.81 %	-36.65 %	30.86 %	188.89 %
Y / Y Revenue Change	14.29 %	-41.28 %	-69.06 %	-38.92 %	180 %
Receivable Turnover Ratio (TTM)	3.58	3.8	4.56	5.88	7.12
MOTS's Total Ranking	# 3369	# 0	# 2475	# 2483	#
Accounts Receivable average collection period days	102	96	80	62	51
Seq. Receivable Change	6.58 %	-25.49 %	-3.77 %	103.85 %	-11.86 %
Seq. Revenue Change	0 %	-25.58 %	-23.89 %	101.79 %	-48.62 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 176
Healthcare Sector	# 507
Overall Market	# 3369

Receivable Turnover Ratio Statistics
High	Average	Low
7.42	4.43	1.71
(Dec 31 2022)		(Sep 30 2019)

MOTS Company Profile • Back to MOTS Efficiency Comparisons • Compare MOTS Receivables Turnover Ratio to its Competitors

Financial Statements
Motus Gi Holdings Inc 's Accounts Receivable	$ 0 Millions	Visit MOTS's Balance sheet
Motus Gi Holdings Inc 's Sales TTM	$ 0 Millions	Visit MOTS's Income Statement
Sources of MOTS's Revenues		Visit MOTS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MOTS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MOTS's Growth Rates	MOTS's Roa	MOTS's Inventory Turnover Ratio	MOTS's Dividend Comparisons
MOTS's Profitability Ratios	MOTS's Roi	MOTS's Asset Turnover Ratio	MOTS's Dividend Growth
MOTS's Valuation Ratios	MOTS's Roe	MOTS's Financial Strength Ratios	MOTS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Zomedica Corp	11.07	$ 24.953 Millions	$ 2.254 Millions
Sunlink Health Systems Inc	10.94	$ 35.981 Millions	$ 3.289 Millions
Semler Scientific inc	10.86	$ 65.881 Millions	$ 6.064 Millions
Protalix Biotherapeutics inc	10.84	$ 59.654 Millions	$ 5.504 Millions
Medinotec Inc	10.83	$ 5.020 Millions	$ 0.464 Millions
Onemednet Corporation	10.74	$ 1.088 Millions	$ 0.101 Millions
Stablecoin Development Corporation	10.73	$ 13.502 Millions	$ 1.258 Millions
Lensar Inc	10.72	$ 44.500 Millions	$ 4.151 Millions
Palvella Therapeutics Inc	10.71	$ 40.927 Millions	$ 3.820 Millions
National Healthcare Corp	10.65	$ 1,169.157 Millions	$ 109.766 Millions
Mannkind Corporation	10.64	$ 224.599 Millions	$ 21.106 Millions
Thermogenesis Holdings Inc	10.57	$ 8.561 Millions	$ 0.810 Millions
Strata Critical Medical Inc	10.50	$ 231.423 Millions	$ 22.030 Millions
Lipella Pharmaceuticals Inc	10.47	$ 0.477 Millions	$ 0.046 Millions
American Oncology Network Inc	10.43	$ 1,339.793 Millions	$ 128.511 Millions
Option Care Health Inc	10.24	$ 4,431.875 Millions	$ 432.691 Millions
Tandem Diabetes Care Inc	10.18	$ 769.825 Millions	$ 75.647 Millions
Procyon Corporation	9.95	$ 4.774 Millions	$ 0.480 Millions
Quidelortho Corp	9.93	$ 2,862.700 Millions	$ 288.225 Millions
Co diagnostics Inc	9.90	$ 6.678 Millions	$ 0.675 Millions
Addus Homecare Corp	9.75	$ 1,086.454 Millions	$ 111.398 Millions
Sangamo Therapeutics Inc	9.74	$ 18.756 Millions	$ 1.926 Millions
Viemed Healthcare Inc	9.73	$ 194.045 Millions	$ 19.944 Millions
Immucell Corporation	9.60	$ 19.702 Millions	$ 2.053 Millions
Clearpoint Neuro Inc	9.56	$ 26.161 Millions	$ 2.736 Millions
Revance Therapeutics Inc	9.46	$ 236.645 Millions	$ 25.005 Millions
Escalon Medical Corp	9.44	$ 11.645 Millions	$ 1.233 Millions
Equillium Inc	9.30	$ 37.894 Millions	$ 4.074 Millions
Travere Therapeutics Inc	9.29	$ 183.225 Millions	$ 19.719 Millions
Rockwell Medical inc	9.29	$ 85.392 Millions	$ 9.192 Millions

Date modified: 2026-09-12T06:23:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.